Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0722512B2 - Process for producing optically active α-perfluoroalkylpropionic acid derivative - Google Patents
[go: Go Back, main page]

JPH0722512B2 - Process for producing optically active α-perfluoroalkylpropionic acid derivative - Google Patents

Process for producing optically active α-perfluoroalkylpropionic acid derivative

Info

Publication number
JPH0722512B2
JPH0722512B2 JP4168386A JP4168386A JPH0722512B2 JP H0722512 B2 JPH0722512 B2 JP H0722512B2 JP 4168386 A JP4168386 A JP 4168386A JP 4168386 A JP4168386 A JP 4168386A JP H0722512 B2 JPH0722512 B2 JP H0722512B2
Authority
JP
Japan
Prior art keywords
optically active
perfluoroalkylpropionic
acid derivative
acid
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4168386A
Other languages
Japanese (ja)
Other versions
JPS62201588A (en
Inventor
智哉 北爪
Original Assignee
エフテック株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エフテック株式会社 filed Critical エフテック株式会社
Priority to JP4168386A priority Critical patent/JPH0722512B2/en
Publication of JPS62201588A publication Critical patent/JPS62201588A/en
Publication of JPH0722512B2 publication Critical patent/JPH0722512B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention 【産業上の利用分野】[Industrial applications]

本発明は、一般式 (式中、Rfは、ペルフルオロアルキル基であり、Rは、
水酸基、置換若しくは無置換のアミノ基又は置換若しく
は無置換のチオール基である。)で表される光学活性な
α−ペルフルオロアルキルプロピオン酸誘導体の製造方
法に関する。 本発明によりえられる前記一般式(I)で表される光学
活性なα−ペルフルオロアルキルアクリル酸誘導体のう
ちβ−位に水酸基を有する2−トリフルオロメチル−3
−ヒドロキシプロピオン酸は、医療品中間体として有用
な5−トリフルオロメチルウラシルに導くことができる
化合物である。
The present invention has the general formula (In the formula, Rf is a perfluoroalkyl group, and R is
It is a hydroxyl group, a substituted or unsubstituted amino group, or a substituted or unsubstituted thiol group. And a method for producing an optically active α-perfluoroalkylpropionic acid derivative represented by Among the optically active α-perfluoroalkylacrylic acid derivatives represented by the general formula (I) obtained by the present invention, 2-trifluoromethyl-3 having a hydroxyl group at the β-position.
-Hydroxypropionic acid is a compound that can lead to 5-trifluoromethyluracil useful as an intermediate for medical products.

【従来の技術】[Prior art]

従来、光学活性なα−ペルフルオロアルキルプロピオン
酸誘導体の製造方法は知られていない。
Heretofore, a method for producing an optically active α-perfluoroalkylpropionic acid derivative has not been known.

【発明の解決した問題点】[Problems solved by the invention]

本発明者は、医療品の中間体として有用な光学活性なα
−ペルフルオロプロピオン酸誘導体の製造方法について
鋭意検討した結果、本発明を見出し完成した。
The present inventor has found that an optically active α useful as an intermediate for medical products.
As a result of extensive studies on a method for producing a perfluoropropionic acid derivative, the present invention has been completed and found.

【発明の構成】[Constitution of the invention]

本発明は、エステラーゼ又はセルラーゼの存在下、一般
(式中、Rfは、ペルフルオロアルキル基である。)で表
されるα−ペルフルオロアルキルアクリル酸と一般式 RH −(III) (式中、Rは、水酸基、置換若しくは無置換のアミノ基
又は置換若しくは無置換のチオール基である。で表され
る化合物を反応させ、前記一般式 (式中、R及びRfは、前記と同じである。)で表される
光学活性なα−ペルフルオロプロピオン酸誘導体を製造
するものである。 本発明の前記一般式(II)で表されるα−ペルフルオロ
アルキルアクリル酸は、工業的に容易に入手可能な化合
物である。この化合物のRf基は、トリフルオロメチル
基、ペンタフルオロエチル基などを例示することができ
る。又、前記一般式(III)で表される化合物も工業的
に容易に入手可能な化合物であり、例えば、水、アンモ
ニア、ジエチルアミン、ジプロピルアミン等のアルキル
アミン、チオフェノール等のアリールチオールを例示す
ることができる。 本発明は、エステラーゼ又はセルラーゼの存在下に行う
ことが必要である。エステラーゼとしては、pig liver
esterase,α−chymotrypsin,lipase−MY(名糖産業
(株)製、Candida cylindracea)等を、又、セルラー
ゼとしては、Trichoderma viride等を例示することがで
きる。 反応を行うにあたっては、緩衝溶液中で行ことが好まし
くKH2PO4−Na2HPO4緩衝溶液を好適に使用できる。 反応温度は30〜45℃の範囲が目的物が効率良く得られる
点で好ましい。 以下、実施例により、本発明を更に詳細に説明する。 実施例 1 KH2PO4(0.45g)とNa2HPO4(7.57g)を蒸留水に溶かし
て1.7の溶液とした。この緩衝溶液(pH8.0,50ml)にl
ipase−MY(Candida cylindracea,名糖産業製5g)を懸
濁させ、恒温槽中40〜41℃で15分間攪拌した。その溶液
にα−トリフルオロメチルアクリル酸(1.5g,10mmol)
を加え、40〜41℃で3日間反応させた。反応液を1規定
塩酸(10ml)で酸性にしたのち、生成物を酢酸エチル
(50ml)で3回抽出した。抽出液を硫酸マグネシウムで
乾燥したのち、酢酸エチルを留去し、残留物を減圧蒸留
し(+)−2−トリフロオロメチル−3−ヒドロキシプ
ロピオン酸を得た。bp.91℃/0.6mmHg 収率 48% 光学純度の決定は、常法によりヒドロキシエステル体を
合成し、この化合物と(+)−α−メトキシ−α−トリ
フルオロメチルフェニル酢酸クロリドからエステル体を
得て19F−NMRで積算した。 実施例 2〜3 pig liver esterase(90μ Sigma社製)及びα−chym
otrypsin(1g Sigma社製)を使用して上記の条件で反応
させ、後処理も全く同様に行った。その結果を実施例1
の結果と合わせて表1に示した。光学純度の決定は、実
施例1と同様にして行った。 実施例 4 実施例1で用いた緩衝溶液(pH8.0,50ml)にpig liver
esterase(90μ Sigma社製)を加え、恒温槽中40〜41
℃で15分間攪拌した。その溶液に2−トリフルオロメチ
ルプロペン酸(1.5g,10mmol)とジエチルアミン(8.8g,
12mmol)を加え、40〜41℃で92時間反応させた。反応液
を1規定塩酸(10ml)で酸性にしたのち、生成物を酢酸
エチル(50ml)で3回抽出した。抽出液を硫酸マグネシ
ウムで乾燥したのち、酢酸エチルを留去し、残留物をシ
リカゲルクロマトグラムを用い留出溶媒としてヘキサン
−ジエチルエーテル(5:1)を使用して2−トリフルオ
ロメチル−3−N,N−ジエチルアミノプロピオン酸を得
た。収率39%1 H NMR(DMSO−d6):δ1.17(CH3),(3.16〜3.83
(6H),4.00(m,CH),8.30(br.1H)19 F NMR(DMSO−d6;外部標準CF3CO2H):δ−10.8ppm
(d,JCF3-CH=8.5Hz) 尚、光学純度は、第一化学薬品(株)より市販されてい
る「光学純度を測定できる新しいNMRシフト試薬(+)
又は(−)ジ(ペルフルオロ−2−プロポキシプロピオ
ニル)メタンのランタニド錯体を使用し決定した。 実施例 5 実施例1で用いた緩衝溶液(pH8.0,50ml)にpig liver
esterase(90μ Siguma社製)を加え恒温槽中40〜41
℃で15分間攪拌した。その溶液にチオフェノール(1.3
g,12mmol)とα−トリフルオロメチルアクリル酸(1.5
g,10mmol)を加え、40〜41℃で24時間反応させた。反応
液を1規定塩酸(10ml)で酸性にしたのち生成物を酢酸
エチル(50ml)で3回抽出した。抽出液を硫酸マグネシ
ウムで乾燥したのち、酢酸エチルを留去し、残留物をシ
リカゲルクロマトグラムを用い、留出溶媒としてヘキサ
ン−ジエチルエーテル(5:1)を使用して目的とする2
−トルフルオロメチル−3−フェニルチオプロピオン酸
を得た。収率64%1 H NMR(DMSO−d6):δ3.20〜3.30(3H),7.4(Ar−
H),11.7(Co2H)19 F NMR(DMSO−d6;外部標準CF3CO2H):δ−10.3(d,
JCF3-CH=8.0Hz) 尚、光学純度の測定は実施例4の方法と同様に行った。
結果を実施例4の結果とあわせて表2にまとめた。
The present invention has the general formula in the presence of esterase or cellulase. (In the formula, Rf is a perfluoroalkyl group.) And α-perfluoroalkylacrylic acid represented by the general formula RH- (III) (wherein, R is a hydroxyl group, a substituted or unsubstituted amino group or a substituted amino group). Alternatively, it is an unsubstituted thiol group. (In the formula, R and Rf are the same as above.) An optically active α-perfluoropropionic acid derivative represented by the formula is produced. The α-perfluoroalkylacrylic acid represented by the general formula (II) of the present invention is a compound that is industrially easily available. Examples of the Rf group of this compound include a trifluoromethyl group and a pentafluoroethyl group. The compounds represented by the general formula (III) are also industrially easily available compounds, and examples include water, ammonia, alkylamines such as diethylamine and dipropylamine, and arylthiols such as thiophenol. can do. The present invention needs to be carried out in the presence of esterase or cellulase. As an esterase, pig liver
Examples include esterase, α-chymotrypsin, lipase-MY (manufactured by Meito Sangyo Co., Ltd., Candida cylindracea) and the like, and examples of cellulase include Trichoderma viride and the like. The reaction is preferably carried out in a buffer solution, and a KH 2 PO 4 —Na 2 HPO 4 buffer solution can be preferably used. The reaction temperature is preferably in the range of 30 to 45 ° C. in order to efficiently obtain the desired product. Hereinafter, the present invention will be described in more detail with reference to Examples. Example 1 KH 2 PO 4 (0.45 g) and Na 2 HPO 4 (7.57 g) were dissolved in distilled water to give a solution of 1.7. L In this buffer solution (pH 8.0, 50 ml)
ipase-MY (Candida cylindracea, 5 g manufactured by Meito Sangyo Co., Ltd.) was suspended and stirred in a constant temperature bath at 40 to 41 ° C. for 15 minutes. Α-Trifluoromethylacrylic acid (1.5g, 10mmol) in the solution
Was added, and the mixture was reacted at 40 to 41 ° C for 3 days. The reaction mixture was acidified with 1N hydrochloric acid (10 ml), and the product was extracted 3 times with ethyl acetate (50 ml). The extract was dried over magnesium sulfate, ethyl acetate was distilled off, and the residue was distilled under reduced pressure to obtain (+)-2-trifluoromethyl-3-hydroxypropionic acid. bp.91 ° C / 0.6mmHg Yield 48% The optical purity was determined by synthesizing a hydroxy ester compound by a conventional method, and obtaining the ester compound from this compound and (+)-α-methoxy-α-trifluoromethylphenylacetic acid chloride. Obtained and integrated by 19 F-NMR. Examples 2-3 pig liver esterase (manufactured by 90μ Sigma) and α-chym
Using otrypsin (manufactured by 1 g Sigma), the reaction was carried out under the above conditions, and the post-treatment was carried out in exactly the same manner. The results are shown in Example 1.
The results are shown in Table 1. The optical purity was determined in the same manner as in Example 1. Example 4 Pig liver was added to the buffer solution (pH 8.0, 50 ml) used in Example 1.
Add esterase (90μ Sigma) and add 40-41 in a constant temperature bath.
Stirred at 15 ° C for 15 minutes. 2-trifluoromethylpropenoic acid (1.5 g, 10 mmol) and diethylamine (8.8 g,
(12 mmol) was added and the mixture was reacted at 40 to 41 ° C. for 92 hours. The reaction mixture was acidified with 1N hydrochloric acid (10 ml), and the product was extracted 3 times with ethyl acetate (50 ml). After the extract was dried over magnesium sulfate, ethyl acetate was distilled off, and the residue was subjected to silica gel chromatogram using hexane-diethyl ether (5: 1) as a solvent for distilling 2-trifluoromethyl-3-. N, N-diethylaminopropionic acid was obtained. Yield 39% 1 H NMR (DMSO-d 6 ): δ1.17 (CH 3 ), (3.16 to 3.83)
(6H), 4.00 (m, CH), 8.30 (br.1H) 19 F NMR (DMSO-d 6 ; external standard CF 3 CO 2 H): δ-10.8 ppm
(D, J CF3-CH = 8.5Hz) The optical purity is "New NMR shift reagent (+) that can measure optical purity" commercially available from Daiichi Pure Chemicals Co., Ltd.
Alternatively, it was determined using a lanthanide complex of (-) di (perfluoro-2-propoxypropionyl) methane. Example 5 Pig liver was added to the buffer solution (pH 8.0, 50 ml) used in Example 1.
Add esterase (manufactured by 90μ Siguma) 40-41 in a constant temperature bath
Stirred at 15 ° C for 15 minutes. Add thiophenol (1.3
g, 12 mmol) and α-trifluoromethylacrylic acid (1.5
g, 10 mmol) was added and reacted at 40 to 41 ° C. for 24 hours. The reaction mixture was acidified with 1N hydrochloric acid (10 ml), and the product was extracted 3 times with ethyl acetate (50 ml). After the extract was dried over magnesium sulfate, ethyl acetate was distilled off, and the residue was purified by silica gel chromatogram using hexane-diethyl ether (5: 1) as a distilling solvent to obtain the target compound.
-Trifluoromethyl-3-phenylthiopropionic acid was obtained. Yield 64% 1 H NMR (DMSO-d 6 ): δ 3.20 to 3.30 (3H), 7.4 (Ar-
H), 11.7 (Co 2 H) 19 F NMR (DMSO-d 6 ; external standard CF 3 CO 2 H): δ-10.3 (d,
J CF3-CH = 8.0 Hz) The optical purity was measured in the same manner as in Example 4.
The results are summarized in Table 2 together with the results of Example 4.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】エステラーゼ又はセルラーゼの存在下、一
般式 で表わされるα−ペルフルオロアクリル酸と一般式 RH で表わされる化合物とを反応させることからなる、一般
で表わされる光学活性なα−ペルフルオロアルキルプロ
ピオン酸誘導体の製造方法(式中、Rfは、ペルフルオロ
アルキル基であり、Rは、水酸基、置換若しくは無置換
のアミノ基又は置換若しくは無置換のチオール基であ
る。)。
1. The general formula in the presence of esterase or cellulase The general formula consisting of reacting α-perfluoroacrylic acid represented by and a compound represented by the general formula RH A method for producing an optically active α-perfluoroalkylpropionic acid derivative represented by: (wherein, Rf is a perfluoroalkyl group, R is a hydroxyl group, a substituted or unsubstituted amino group, or a substituted or unsubstituted thiol group. is there.).
JP4168386A 1986-02-28 1986-02-28 Process for producing optically active α-perfluoroalkylpropionic acid derivative Expired - Lifetime JPH0722512B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4168386A JPH0722512B2 (en) 1986-02-28 1986-02-28 Process for producing optically active α-perfluoroalkylpropionic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4168386A JPH0722512B2 (en) 1986-02-28 1986-02-28 Process for producing optically active α-perfluoroalkylpropionic acid derivative

Publications (2)

Publication Number Publication Date
JPS62201588A JPS62201588A (en) 1987-09-05
JPH0722512B2 true JPH0722512B2 (en) 1995-03-15

Family

ID=12615226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4168386A Expired - Lifetime JPH0722512B2 (en) 1986-02-28 1986-02-28 Process for producing optically active α-perfluoroalkylpropionic acid derivative

Country Status (1)

Country Link
JP (1) JPH0722512B2 (en)

Also Published As

Publication number Publication date
JPS62201588A (en) 1987-09-05

Similar Documents

Publication Publication Date Title
DE69701840T2 (en) METHOD FOR THE ASYMMETRICAL SYNTHESIS OF S-ACYLATED DERIVATIVES OF 2-MERCAPTOMETHYL-3-PHENYL PROPIONIC ACID AND THE USE THEREOF FOR THE SYNTHESIS OF N-MERCAPTOACYL AMINO ACID DERIVATIVES
JPH0722512B2 (en) Process for producing optically active α-perfluoroalkylpropionic acid derivative
JP3129775B2 (en) Method for producing optically active secondary alcohol compound
JPH10245369A (en) Production of serine derivative
EP0239122B1 (en) Process for the enzymatic resolution of racemic 2-amino-1-alkanols
JP3638644B2 (en) Method for producing optically active chroman compound
KR0144453B1 (en) Process for producing beta-lactamase inbibitor
KR0163770B1 (en) Method for preparing 3,4-epoxybutyrate and intermediates therefor
JP3129776B2 (en) Method for producing optically active α-hydroxyalkene derivative
DE68907032T2 (en) Process for the preparation of 1,4-bridged cyclohexane carboxylic acid derivatives and their use.
JP3072150B2 (en) Method for producing optically active [3] (1,1 ') ferrocenophanes
JP3673603B2 (en) Process for producing optically active 2,4,4-trimethyl-2-cyclohexen-1-ol and esters thereof
JP4093608B2 (en) Process for producing optically active 2-phenoxypropionic acid
JPH05227988A (en) Preparation of (2r,3e)-halo-3-butene-2-ol
JPH0551590B2 (en)
JP3256259B2 (en) Method for producing sulfone derivative
JP3828197B2 (en) Process for producing optically active alkali metal salt of 3- (p-methoxyphenyl) glycidic acid
JP2974181B2 (en) A new method for producing cyclobutanol
JPH01100147A (en) Optically active malonic acid ester derivative
JPH1129572A (en) Purification of nucleic acid derivative
JP2538231B2 (en) Process for producing optically active 4-pentene-2-ol derivative
FR2590894A1 (en) AMINO-4-BUTANOIC ACID DERIVATIVES, PROCESS FOR PREPARING SAME AND USE THEREOF
JPS60130539A (en) Preparation of optically active styrene halohydrin
JPH10218840A (en) Production of optically active cyclopropane derivative
JPH0812658A (en) Production of sydnones